Section I
11 – 20 of 4892
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
The DNA methylation landscape of primary triple-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Cellular and molecular cartography of muscle-invasive bladder cancer: Who benefits from neoadjuvant chemotherapy?
2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Global Transcriptional Complexity of Estrogen Receptor Low Positive Breast Cancers in a Prospective Swedish Population-based SCAN-B Cohort
2025) In Clinical cancer research : an official journal of the American Association for Cancer Research(
- Contribution to journal › Article
-
Mark
Metabolic syndrome is associated with breast cancer mortality : A systematic review and meta-analysis
(
- Contribution to journal › Article
-
Mark
Reply to Laila Schneidewind, Fabian P. Stangl, Jennifer Kranz, and Gernot Bonkat's Letter to Editor re : Fredrik Liedberg, Evanguelos Xylinas, Paolo Gontero. Quinolone Prophylaxis in Conjunction with Bacillus Calmette-Guérin Instillations for Bladder Cancer: Time To Reconsider the Evidence and Open the Quinolone Box? Eur Urol Focus 2024;10:564–6
2025) In European Urology Focus(
- Contribution to journal › Debate/Note/Editorial
-
Mark
High prevalence of atrial conduction abnormalities in Lewy body disease – a marker of cardiac complications?
2025) In GeroScience(
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma : anatomical site matters
(
- Contribution to journal › Article
-
Mark
Adaptive radiotherapy in locally advanced head and neck cancer : The importance of reduced margins
(
- Contribution to journal › Article
-
Mark
Reirradiation in Paediatric Tumours of the Central Nervous System : Outcome and Side Effects After Implementing National Guidelines
(
- Contribution to journal › Article
-
Mark
Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment
(
- Contribution to journal › Article